PURE Bioscience (OTCMKTS:PURE) Issues Quarterly Earnings Results

PURE Bioscience (OTCMKTS:PURE) announced its earnings results on Monday. The company reported ($0.01) earnings per share (EPS) for the quarter, Zacks reports.

PURE Bioscience Stock Up 25.1 %

OTCMKTS PURE opened at $0.07 on Tuesday. PURE Bioscience has a 52 week low of $0.05 and a 52 week high of $0.16. The business’s fifty day simple moving average is $0.07 and its 200-day simple moving average is $0.08. The firm has a market cap of $7.70 million, a PE ratio of -1.72 and a beta of 0.35.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.